dc.creatorGoncalves E.M.
dc.creatorDos Santos M.T.
dc.creatorBertoncelli M.D.F.
dc.creatorBussamara G.A.
dc.creatorFuzzari T.
dc.creatorLima V.A.
dc.creatorPesotte L.C.
dc.creatorPitori V.
dc.creatorGenari S.C.
dc.date2007
dc.date2015-06-30T18:46:16Z
dc.date2015-11-26T14:33:56Z
dc.date2015-06-30T18:46:16Z
dc.date2015-11-26T14:33:56Z
dc.date.accessioned2018-03-28T21:37:19Z
dc.date.available2018-03-28T21:37:19Z
dc.identifier
dc.identifierCytologia. , v. 72, n. 2, p. 155 - 160, 2007.
dc.identifier114545
dc.identifier10.1508/cytologia.72.155
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-34548297906&partnerID=40&md5=7e67bc2e46750ef6ffc3dc6813b5a368
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/104692
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/104692
dc.identifier2-s2.0-34548297906
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1247977
dc.descriptionCisplatin is an antineoplastic agent used to treat solid malignancies, such as ovarian, testicular and bladder tumors. Studies have been shown that cisplatin induces genotoxic effects and chromosomal alterations that can result in genetic and chromosomal instability. In this work, we investigated the effects of cisplatin on the cytogenetic traits of cultured V79 cells based on the modal chromosome number, mitotic index, frequency of polyploidy and number of aneuploid metaphases. Cisplatin-treated V79 cells showed an altered chromosome number distribution, as well as an enhanced mitotic index, frequency of polyploidy and number of aneuploid metaphases. These alterations were probably related to the genetic instability produced by cisplatin. In addition, these cells showed characteristics associated with neoplastic development that corresponded to neoplastic processes related to the use of cisplatin in chemotherapy. © 2007 The Japan Mendel Society.
dc.description72
dc.description2
dc.description155
dc.description160
dc.descriptionAllavena, P., Pirovano, P., Bonazzi, C., Colombo, N., Mantovani, A., D'Incalci, M., In vitro and in vivo effects of cisplatin on the generation of lymphokine-activated killer cells (1990) J. Natl. Cancer Inst, 82, pp. 139-142
dc.descriptionBarrett, J.C., Cell culture models of multistep carcinogenesis (1985) IARC Sci. Publ, 58, pp. 181-202
dc.descriptionBorenfreund, E., Babich, H., Martin-Alguacil, N., Effect of methylazoxymethanol acetate on bluegill sunfish cell cultures in vitro (1989) Ecotoxicol. Environ. Saf, 17, pp. 297-307
dc.descriptionBradley, M.O., Bhuyan, B., Francis, M.C., Langenbach, R., Peterson, A., Huberman, E., Mutagenesis by chemical agents in V79 chinese hamster cells: A review and analysis of the literature. A report of the Gene-Tox Program (1981) Mutat. Res, 87, pp. 81-142
dc.descriptionChambers, S.K., Chopyk, R.L., Chambers, J.T., Schwartz, P.E., Duffy, T.P., Development of leukemia after doxorubicin and cisplatin treatment for ovarian cancer (1989) Cancer, 64, pp. 2459-2461
dc.descriptionChang, W., Little, J., Persistently elevated frequency of spontaneous mutations in progeny of CHO clones surviving X-irradiation: Association with delayed reproductive death phenotype (1992) Mutat. Res, 270, pp. 191-199
dc.descriptionDeitch, A.D., Sawicki, S.G., Effects of cordycepin on microtubules of cultured mammalian cells (1979) Exp. Cell Res, 118, pp. 1-13
dc.descriptionGenari, S.C., Wada, M.L.F., Behavioural differences and cytogenetical analysis of a transformed cellular population derived from a Vero cell line (1995) Cytobios, 81, pp. 17-25
dc.descriptionGenari, S.C., Wada, M.L.F., Dolder, M.A.H., Wada, M.L.F., Scanning and transmission electron microscopy of transformed Vero cells, with altered in vitro growth characteristics (1996) J. Submicrosc. Cytol. Pathol, 28, pp. 565-572
dc.descriptionGenari, S.C., Wada, M.L.F., Dolder, M.A.H., Wada, M.L.F., Wada, M.L.F., Effects of nutritional stress conditions on the ploidy and growth of human amniotic cells (2000) In Vitro Cell. Develop. Biol, 36, pp. 147-150
dc.descriptionGenari, S.C., Wada, M.L.F., Dolder, M.A.H., Wada, M.L.F., Wada, M.L.F., The influence of nutritional stress on the differentiation of epithelial cells in vitro (2003) Braz. J. Morphol. Sci, 20, pp. 135-140
dc.descriptionGiaccone, G., Clinical perspectives on platinum resistance (2000) Drugs, 59, pp. 9-17
dc.descriptionGilvarry, U., Farrel, D., Lynch, V., Moriarty, M., Dooley, M., Law, E., Clynes, M., Cytological differences between normal and malignant human cell populations in culture (1990) Cancer Res, 50, pp. 3390-3393
dc.descriptionGonzález, V.M., Fuertes, M.A., Alonso, C., Pérez, J.M., Is cisplatin-induced cell death always produced by apoptosis? (2001) Mol. Pharmacol, 59, pp. 657-663
dc.descriptionHadnagy, W., Seemayer, N.H., Cytotoxic and genotoxic effects of extract of particulate emission from a gasoline-powered engine (1988) Environ. Mol. Mutagen, 12, pp. 385-396
dc.descriptionHarper, K., Lorimore, S., Wright, E., Delayed appearance of radiation-induced mutations at the Hprt locus in murine hematopoietic cells (1997) Exp. Hematol, 25, pp. 263-269
dc.descriptionHolliday, R., Chromosome error propagation and cancer (1989) Trends Genet, 5, pp. 42-45
dc.descriptionLittle, J., Induction of genetic instability by ionizing radiation (1999) C. R. Acad. Sci. III, 322, pp. 127-134
dc.descriptionLothschutz, D., Jennewein, M., Pahl, S., Lausberg, H.F., Eichler, A., Mutschler, W., Hanselmann, R.G., Oberringer, M., Polyploidization and centrosome hyperamplification in inflammatory bronchi (2002) Inflamm. Res, 51, pp. 416-422
dc.descriptionMead, G.M., Green, J.A., Macbeth, F.R., Williams, C.J., Whitehouse, J.M., Buchanan, R., Second malignancy after cisplatin, vinblastine, and bleomycin (PVB) chemotherapy: A case report (1983) Cancer Treat. Rep, 67, p. 410
dc.descriptionOhshima, S., Induction of genetic instability and chromosomal instability by nickel sulfate in V79 Chinese hamster cells (2003) Mutagenesis, 18, pp. 133-137
dc.descriptionReedjik, J., The mechanism of action of platinum anti-cancer drugs (1987) Pure Appl. Chem, 59, pp. 181-192
dc.descriptionRosenberg, B., VanCamp, L., Trosko, J.E., Mansour, V.H., Platinum compounds: A new class of potent antitumor agents (1969) Nature, 222, pp. 385-386
dc.descriptionSrb, V., Prochazkova, J., Monitoring of effects of cis-diamminedichloroplatinum II. Part I. Cytogenetic analysis in vitro (1983) Neoplasma, 30, pp. 463-467
dc.descriptionStorchova, Z., Pellman, D., From polyploidy to aneuploidy, genome instability and cancer (2004) Nat. Rev. Mol. Cell. Biol, 5, pp. 45-54
dc.descriptionTandon, P., Sodhi, A., cis-Dichlorodiammine platinum (II) induced aberrations in mouse bone-marrow chromosomes (1985) Mutat. Res, 156, pp. 193-197
dc.descriptionTurnbull, D., Popescu, N.C., DiPaolo, J.A., Myhr, B.C., cis-platinum(II)diammine dichloride causes mutation, transformation, and sister-chromatid exchanges in cultured mammalian cells (1979) Mutat. Res, 66, pp. 267-275
dc.descriptionVan Imhoff, G.W., Sleijfer, D.T., Breuning, M.H., Anders, G.J., Mulder, N.H., Halie, M.R., Acute nonlymphocytic leukemia 5 years after treatment with cisplatin, vinblastine, and bleomycin for disseminated testicular cancer (1986) Cancer, 57, pp. 984-987
dc.descriptionWiencke, J.K., Cervenka, J., Paulus, H., Mutagenic activity of anticancer agent cis-dichlorodiammine platinum-II (1979) Mutat. Res, 68, pp. 69-77
dc.descriptionZhu, H., Gooderham, N., Neoplastic transformation of human lung fibroblast MRC-5 SV2 cells induced by benzo[a]pyrene and confluence culture (2002) Cancer Res, 62, pp. 4605-4609
dc.languageen
dc.publisher
dc.relationCytologia
dc.rightsaberto
dc.sourceScopus
dc.titleCisplatin-induced Cytogenetic Alterations In V79 Cells
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución